- R&D Pipeline
- Season 2 (2021-2030)
| Modality | Indication | Targets | Stage | Company | Project No. | Detail | |
|---|---|---|---|---|---|---|---|
| 1 | Non.clinical study completion and manufacturing system development of CX301 for the development of orphan drug on malignant ischemic stroke | ||||||
| Others | Cerebral infarction | ROS.related inflammation | Preclinical | Cenyx Biotech Inc. | RS-2023-00284156 | ||
| 2 | Development of an exosome-mediated intracellular therapeutic protein delivery system for Parkinson's disease | ||||||
| Others | Parkinson's disease | Parkin, PGC-1α | Hit | Sungkyunkwan University | HN21C1266 | ||